Dopamine Agonists: all 968 studies that test it

Page 3 of 10. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.

• A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's DiseaseCompletedNCT01736176Phase 3Results posted
• Cabergoline in Metastatic Breast CancerCompletedNCT01730729Early Phase 1Results posted
• A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus TrialCompletedNCT01727726Phase 3Results posted
• Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727713Phase 3Results posted
• Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01727700Phase 3Results posted
• A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's DiseaseCompletedNCT01723904Phase 3Results posted
• A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's DiseaseCompletedNCT01711866Phase 4Results posted
• Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I DisorderCompletedNCT01710709Phase 3Results posted
• Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus RhythmCompletedNCT01691313Phase 2Results posted
• Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaCompletedNCT01683058Phase 3Results posted
• Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive DisorderCompletedNCT01670279Phase 1Results posted
• Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With SchizophreniaCompletedNCT01668797Phase 3Results posted
• Vision Response to Dopamine ReplacementTerminatedNCT01663935Phase 2Results posted
• Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With SchizophreniaCompletedNCT01663532Phase 3Results posted
• Multicenter, Open-label, Safety and Tolerability StudyCompletedNCT01649557Phase 2Results posted
• An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With SchizophreniaCompletedNCT01646827Phase 1Results posted
• Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease PatientsCompletedNCT01646268Phase 3Results posted
• Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease PatientsCompletedNCT01646255Phase 3Results posted
• A Dose-ranging Study for SPM 962 in Parkinson's Disease PatientsCompletedNCT01634243Phase 2Results posted
• A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease PatientsCompletedNCT01631825Phase 3Results posted
• A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease PatientsCompletedNCT01631812Phase 2Results posted
• A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease PatientsCompletedNCT01628965Phase 2/3Results posted
• A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease PatientsCompletedNCT01628926Phase 3Results posted
• A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease PatientsCompletedNCT01628848Phase 2Results posted
• Phase 3 Extension Study of Dexpramipexole in ALSTerminatedNCT01622088Phase 3Results posted
• Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant ProlactinomasCompletedNCT01620138Phase 2/3Results posted
• A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic DisorderCompletedNCT01617460Phase 3Results posted
• A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic DisorderCompletedNCT01617447Phase 3Results posted
• Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)CompletedNCT01569464Phase 3Results posted
• A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067CompletedNCT01568034Phase 2Results posted
• A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs SyndromeCompletedNCT01562743Phase 2Results posted
• Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than AripiprazoleCompletedNCT01552772Phase 1Results posted
• A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring HemodialysisCompletedNCT01537042Phase 3Results posted
• Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal DysfunctionTerminatedNCT01536015Phase 3Results posted
• Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/BenserazideCompletedNCT01533116Phase 1Results posted
• PharmacoMRI of Parkinson DiseaseCompletedNCT01528592Not applicableResults posted
• Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease PatientsCompletedNCT01523301Phase 4Results posted
• Study of BIA 9-1067 to Investigate Its Effect on Levodopa PharmacokineticCompletedNCT01519284Phase 1Results posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleTerminatedNCT01509053Phase 3Results posted
• Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs SyndromeCompletedNCT01498120Phase 2Results posted
• Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs SyndromeCompletedNCT01495793Phase 2Results posted
• A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's DiseaseCompletedNCT01494532Phase 4Results posted
• Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's DiseaseCompletedNCT01479127Phase 2Results posted
• The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's DiseaseCompletedNCT01470859Not applicableResults posted
• Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With KetoconazoleCompletedNCT01468558Phase 1Results posted
• A Long-term Trial of OPC-34712 in Patients With SchizophreniaCompletedNCT01456897Phase 3Results posted
• Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs SyndromeCompletedNCT01455012Phase 4Results posted
• A Dose-finding Trial of OPC-34712 in Patients With SchizophreniaCompletedNCT01451164Phase 2/3Results posted
• Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive DisorderCompletedNCT01447576Phase 2Results posted
• Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's TypeCompletedNCT01438060Phase 3Results posted
• Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot AripiprazoleCompletedNCT01432444Phase 3Results posted
• Augmenting Language Therapy for Aphasia: LevodopaCompletedNCT01429077Phase 2/3Results posted
• Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective DisorderCompletedNCT01423916Phase 1Results posted
• VA Augmentation and Switching Treatments for Improving Depression OutcomesCompletedNCT01421342Phase 3Results posted
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)CompletedNCT01418352Phase 3Results posted
• Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01418339Phase 3Results posted
• Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's DisorderCompletedNCT01416441Phase 3Results posted
• Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety StudyCompletedNCT01411137Phase 3Results posted
• High and Low Dose Carbidopa Treatment of Parkinson's DiseaseCompletedNCT01399905Phase 2Results posted
• Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With SchizophreniaCompletedNCT01397786Phase 3Results posted
• Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute SchizophreniaCompletedNCT01396421Phase 3Results posted
• Efficacy Study of OPC-34712 in Adults With Acute SchizophreniaCompletedNCT01393613Phase 3Results posted
• Cognitive Remediation for Cocaine DependenceCompletedNCT01393457Phase 2Results posted
• Safety Study of R(+)Pramipexole to Treat Early Alzheimer's DiseaseCompletedNCT01388478Phase 2Results posted
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)CompletedNCT01360645Phase 3Results posted
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)CompletedNCT01360632Phase 3Results posted
• Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With SchizophreniaCompletedNCT01338298Not applicableResults posted
• Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)CompletedNCT01333072Phase 4Results posted
• Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor SymptomsCompletedNCT01300819Phase 4Results posted
• A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired SubjectsCompletedNCT01299454Phase 1Results posted
• Aripiprazole Effects on Alcohol Drinking and CravingCompletedNCT01292057Phase 3Results posted
• Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired SubjectsCompletedNCT01289080Phase 1Results posted
• A Trial of Levodopa in Angelman SyndromeCompletedNCT01281475Phase 2/3Results posted
• Phase 3 Study of Dexpramipexole in ALSCompletedNCT01281189Phase 3Results posted
• Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic DisorderCompletedNCT01227668Phase 4Results posted
• Multiple Dose Bioequivalence Study of Pramipexole Extended Release in Chinese Healthy Male VolunteersCompletedNCT01214109Phase 1Results posted
• Carbidopa for the Treatment of Nausea and Vomiting in Familial DysautonomiaCompletedNCT01212484Phase 3Results posted
• Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult VolunteersCompletedNCT01199965Phase 1/2Results posted
• Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) PatientsCompletedNCT01191944Phase 3Results posted
• Levodopa for the Treatment of Residual AmblyopiaCompletedNCT01190813Phase 3Results posted
• Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy SubjectsCompletedNCT01188668Phase 4Results posted
• Trial of L-DOPA as a Treatment to Improve Vision in AlbinismCompletedNCT01176435Phase 2Results posted
• Efficacy & Safety Study of Oral Aripiprazole in Adolescents With SchizophreniaCompletedNCT01149655Phase 3Results posted
• A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066CompletedNCT01130493Phase 3Results posted
• An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With SchizophreniaCompletedNCT01129882Phase 3Results posted
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01123707Phase 3Results posted
• Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.TerminatedNCT01122927Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111565Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111552Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111539Phase 3Results posted
• An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's DiseaseCompletedNCT01096186Phase 3Results posted
• Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial PressureCompletedNCT01089062Phase 1Results posted
• Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)CompletedNCT01084551Phase 3Results posted
• Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting ConditionsCompletedNCT01074463Phase 1Results posted
• Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting ConditionsCompletedNCT01074450Phase 1Results posted
• Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity DisorderCompletedNCT01074294Phase 2Results posted
• Imaging the Nucleus Accumbens in Major Depressed Patients 'Treated With PramipexoleTerminatedNCT01066897Phase 4Results posted
• Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the BodyCompletedNCT01059903Phase 1Results posted
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive DisorderCompletedNCT01052077Phase 2Results posted
• FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum DisordersCompletedNCT01028820Phase 4Results posted

← Dopamine Agonists overview